Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Neurotrope, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R9.htm
EX-32 - SECTION 906 CERTIFICATIONS BY CFO - Neurotrope, Inc.ex_32-2.htm
EX-31 - RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CEO - Neurotrope, Inc.ex_31-1.htm
EX-31 - RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CFO - Neurotrope, Inc.ex_31-2.htm
EX-32 - SECTION 906 CERTIFICATIONS BY CEO - Neurotrope, Inc.ex_32-1.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R11.htm
10-K - FORM 10-K ANNUAL REPORT FOR JANUARY 31, 2012 - Neurotrope, Inc.form_10-k.htm
v2.4.0.6
BALANCE SHEETS (USD $)
Jan. 31, 2012
Jan. 31, 2011
CURRENT ASSETS    
Cash and cash equivalents $ 5,745 $ 8,000
Total current assets 5,745 8,000
TOTAL ASSETS 5,745 8,000
CURRENT LIABILITIES    
Accounts payable & Accrued liabilities    3,600
Total liabilities    3,600
STOCKHOLDERS' EQUITY (DEFICIENCY)    
Capital Stock (Note 4) Authorized: 300,000,000 common shares, $0.0001 par value. Issued and outstanding: 10,200,000 and 9,000,000 common shares at January 31, 2012 and 2011, respectively. 1,020 900
Additional paid-in capital 19,980 8,100
Stock Subscription Receivable    (1,000)
Deficit accumulated during the development stage (15,255) (3,600)
Total Stockholders' Equity (Deficiency) 5,745 4,400
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,745 $ 8,000